Altimmune's stock soars on heavy volume after positive trial data of flu vaccine
Shares of Altimmune Inc. ALT, +7.04% soared 36% in active premarket trade Tuesday, after the immunotherapeutics company reported "additional positive data" from its flu treatment and said it was seeking development and commercialization partnerships. Volume swelled to more than 1.5 million shares, compared with the full-day average of about 1.7 million shares.
Have breaking news sent to your inbox. Subscribe to MarketWatch's free Bulletin emails. Sign up here.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Cash, demand concerns overshadow Tesla's SUV launchShares of Tesla Inc fell about 4 percent on Friday, as investors wondered if its...
Consulte Mais informação »
BioScrip's stock soars after merger deal with Option Care, owned by Walgreens and Madison DearbornShares of BioScrip Inc. soared 32% toward a 4-year high in premarket trade Friday, after the company announced a deal to merge with privately held Option Care Enterprises Inc., a provider of home and alternate treatment site infusion therapy services owned by funds affiliated with Walgreens Boots Alliance Inc. and private-equity firm Madison Dearborn Partners LLC (MDP). BioScrip's stock is halted for news until 7:30 a.m. Eastern. Under terms of the agreement, BioScrip will issue new shares to Option Care's shareholder and Walgreens and MDP will own about 80% of the combined publicly traded company. BioScrip's market capitalization was about $446.9 million as of Thursday's close. "This is a compelling and complementary fit of two leading players in the U.S. infusion market," said BioScrip Chief Executive Daniel Greenleaf. "Together, we will be able to provide a diverse set of life-improving and cost-effective services to more patients across the United States." BioScrip's stock has rallied 31% over the past 12 months, while the SPDR Health Care Select Sector ETF has gained 6.9% and the Dow Jones Industrial Average has tacked on 3.4%.
Consulte Mais informação »
'Disappointing' timing on Model Y crossover pushes Tesla's stock downShares of Tesla Inc. dropped after what analysts described as an underwhelming reveal of the company's latest electric vehicle, the Model Y crossover.
Consulte Mais informação »
AT&T shares rise after Raymond James upgrades, says stock cheap compared to VerizonTelecommunications giant AT&T rose 0.7 percent in the premarket Friday after an analyst at Raymond James upgraded the stock, noting it trades at a more attractive valuation than rival Verizon.
Consulte Mais informação »
Facebook execs are fleeing, and an analyst warns the exodus could be contagious'What they've done is unleashed products out onto the world and don't have control over them,' karaswisher said Facebook is 'going to be regulated' for its most recent week of controversy, including millions of videos of the New Zealand shooting.
Consulte Mais informação »
Lyft opens up its IPO road show, offers 30 million shares
Consulte Mais informação »
Deutsche Bank merger talks with Commerzbank raise job fears, lift sharesDeutsche Bank and Commerzbank faced concerns from workers unions, Chancellor Ang...
Consulte Mais informação »
Cannabis producer Tilray stock rises after losses widen, revenue tops estimatesTilray Inc. shares gained more than 4% in the extended session Monday after the cannabis producer reported wider-than-expected losses but beat Wall Street...
Consulte Mais informação »
Biotech's shares tumble after it says SEC is looking into possible manipulationPolarityTE said the SEC subpoenaed it earlier this month for documents related to any promotion of the company or its securities, among other items.
Consulte Mais informação »
Asian shares steady ahead of Fed meeting; May's Brexit deal in chaosAsian shares treaded water on Tuesday ahead of a U.S. Federal Reserve policy mee...
Consulte Mais informação »